David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$520M |
| 2 |
Accenture
ACN
|
+$474M |
| 3 |
Intel
INTC
|
+$436M |
| 4 |
Adobe
ADBE
|
+$318M |
| 5 |
Northrop Grumman
NOC
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.23B |
| 2 |
Apple
AAPL
|
+$900M |
| 3 |
Microsoft
MSFT
|
+$733M |
| 4 |
Netflix
NFLX
|
+$637M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.68% |
| 2 | Consumer Discretionary | 10.14% |
| 3 | Financials | 7.13% |
| 4 | Healthcare | 6.41% |
| 5 | Industrials | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Molson Coors Class B
TAP
$8.16B
| $32.6M | 0.03% |
642,048
+8,348
| +1% | +$483K |
|
|
BPMC
577
DELISTED
Blueprint Medicines
BPMC
| $32.6M | 0.03% |
302,635
-73,542
| -20% | -$7.36M |
|
578
Zeta Global
ZETA
$7.22B
| $32.6M | 0.03% |
1,847,610
+1,728,005
| +1,445% | +$25.3M |
|
579
CALL
AutoZone
AZO
$49.2B
| $32.6M | 0.03% |
11,000
-40,100
| -78% | -$117M |
|
580
Liberty Live Group Series A
LLYVA
$9.37B
| $32.6M | 0.03% |
868,590
+43,399
| +5% | +$1.62M |
|
581
Fox Factory Holding Corp
FOXF
$916M
| $32.5M | 0.03% |
674,051
+135,542
| +25% | +$6.13M |
|
582
Zoom
ZM
$31.1B
| $32.5M | 0.03% |
548,731
-1,738,492
| -76% | -$107M |
|
583
National Vision
EYE
$1.45B
| $32.5M | 0.03% |
2,479,245
+1,330,023
| +116% | +$21.8M |
|
584
CALL
American Airlines Group
AAL
$9.09B
| $32.4M | 0.03% |
2,858,600
+775,900
| +37% | +$10.2M |
|
585
CALL
ConocoPhillips
COP
$162B
| $32.3M | 0.03% |
282,700
-121,600
| -30% | -$14.8M |
|
586
Warner Music
WMG
$14.2B
| $32.2M | 0.03% |
1,050,210
+497,102
| +90% | +$16M |
|
587
Power Integrations
POWI
$3B
| $32.1M | 0.03% |
457,470
+131,735
| +40% | +$9.46M |
|
588
CALL
C3.ai
AI
$1.59B
| $32M | 0.03% |
1,103,800
+123,800
| +13% | +$3.18M |
|
589
CALL
CVS Health
CVS
$120B
| $31.9M | 0.03% |
539,400
-499,200
| -48% | -$31.2M |
|
590
Transmedics
TMDX
$3.27B
| $31.7M | 0.03% |
+210,271
| New | +$25.2M |
|
591
Citizens Financial Group
CFG
$29.8B
| $31.7M | 0.03% |
878,888
+420,404
| +92% | +$14.7M |
|
592
PUT
Alcoa
AA
$13.6B
| $31.5M | 0.03% |
791,700
-952,500
| -55% | -$36.9M |
|
593
Cooper Companies
COO
$14.9B
| $31.4M | 0.03% |
360,018
+167,061
| +87% | +$15.6M |
|
594
Celldex Therapeutics
CLDX
$3.13B
| $31.3M | 0.03% |
845,560
+272,389
| +48% | +$10.3M |
|
|
SILK
595
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $31.2M | 0.03% |
1,154,781
-444,710
| -28% | -$9.25M |
|
596
CALL
W.W. Grainger
GWW
$62.7B
| $31.1M | 0.03% |
34,500
-35,000
| -50% | -$32.9M |
|
597
Coca-Cola
KO
$396B
| $31.1M | 0.03% |
488,724
-794,499
| -62% | -$49.2M |
|
598
PROG Holdings
PRG
$1.58B
| $31.1M | 0.03% |
896,075
+6,803
| +0.8% | +$235K |
|
599
IDEAYA Biosciences
IDYA
$3.8B
| $31.1M | 0.03% |
884,538
+226,514
| +34% | +$8.97M |
|
600
Lam Research
LRCX
$379B
| $31M | 0.03% |
291,230
+150,790
| +107% | +$14.5M |
|
Similar funds
David Shaw's Q2 2024 Portfolio in Review
As of Q2 2024, David Shaw held 4,975 positions worth $107B, down 8.5% from $117B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $20B in Q2 2024, closing 541 positions and reducing 1,567 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $542M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $258M.
- David Shaw's largest Q2 2024 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 2,917,600 shares worth $258M.
- David Shaw added most to Broadcom in Q2 2024, an estimated $520M increase.
- David Shaw's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $1.23B.
- David Shaw fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $542M.
- David Shaw's ten largest holdings make up 11% of its $107B portfolio in Q2 2024.
- David Shaw opened 693 new positions and closed 541 in Q2 2024.
- David Shaw's portfolio value fell 8.5% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.